Drug intelligence / Profile preview

AAV-Ptprg-shRNA

Development stage
Preclinical
Lead developer
University of Wisconsin School of Medicine and Public Health
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies
Administration
Parenteral
01

Overview

AAV-Ptprg-shRNA is an experimental adeno-associated virus (AAV) vector-based gene therapy tool designed to deliver short hairpin RNA (shRNA) targeting Receptor-type tyrosine-protein phosphatase gamma (PTPRG). Developed by researchers at the University of Wisconsin School of Medicine and Public Health, it is used in preclinical research to knock down Ptprg expression in specific brain regions, such as the orbitofrontal cortex (OFC) and medial prefrontal cortex (mPFC). This knockdown is studied to elucidate the role of PTPRG in synaptic organization and its association with neuropsychiatric disorders, including schizophrenia and bipolar disorder, where Ptprg loss has been linked to behavioral activation and hyperactivity phenotypes.

Other names
AAV-Ptprg-shRNA-GFP
02

Targets

PTPRG (Receptor-type tyrosine-protein phosphatase gamma)

Beyond the preview

Go deeper on AAV-Ptprg-shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAV-Ptprg-shRNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call